A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially deadly RSV.

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

Tim Scott, Cynthia Lummis, and Bo Hines addressed reporters at a fireside chat discussing digital asset market structure legislation.

HHS’ new vaccine panel backs RSV shot, rejects thimerosal in flu vaccines Advertisement By: Paige Twenter Thursday, June 26th, 2025 ...

(Reuters) -U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday for recommending use of Merck's RSV antibody drug for infants 8 months or younger ...